JAZF1: A metabolic actor subunit of the NuA4/TIP60 chromatin modifying complex
- PMID: 37091973
- PMCID: PMC10119425
- DOI: 10.3389/fcell.2023.1134268
JAZF1: A metabolic actor subunit of the NuA4/TIP60 chromatin modifying complex
Abstract
The multisubunit NuA4/TIP60 complex is a lysine acetyltransferase, chromatin modifying factor and gene co-activator involved in diverse biological processes. The past decade has seen a growing appreciation for its role as a metabolic effector and modulator. However, molecular insights are scarce and often contradictory, underscoring the need for further mechanistic investigation. A particularly exciting route emerged with the recent identification of a novel subunit, JAZF1, which has been extensively linked to metabolic homeostasis. This review summarizes the major findings implicating NuA4/TIP60 in metabolism, especially in light of JAZF1 as part of the complex.
Keywords: acetyl-CoA; acetylation; epigenetics; gene expression; lipogenesis; lipolysis.
Copyright © 2023 Mameri and Côté.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- An P., Feitosa M., Ketkar S., Adelman A., Lin S., Borecki I., et al. (2009). Epistatic interactions of CDKN2B-TCF7L2 for risk of type 2 diabetes and of CDKN2B-JAZF1 for triglyceride/high-density lipoprotein ratio longitudinal change: Evidence from the framingham heart study. BMC Proc. 3 (7), S71. 10.1186/1753-6561-3-s7-s71 - DOI - PMC - PubMed
-
- Boesgaard T. W., Gjesing A. P., Grarup N., Rutanen J., Jansson P.-A., Hribal M. L., et al. (2009). Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients--EUGENE2 study. PloS One 4, e7236. 10.1371/journal.pone.0007236 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
